Literature DB >> 8871581

HIV-1 DNA in brains in AIDS and pre-AIDS: correlation with the stage of disease.

S F An1, B Giometto, F Scaravilli.   

Abstract

Seventeen asymptomatic individuals positive for human immunodeficiency virus type 1 (HIV-1) and 16 patients with acquired immunodeficiency syndrome (AIDS), all with polymerase chain reaction evidence of HIV-1 DNA, were selected for quantitative analysis to correlate the levels of HIV-1 DNA in brain tissue with the stage of infection. The AIDS patients either were clinically asymptomatic or presented various abnormalities. Neuropathological lesions were assessed by morphological and immunohistochemical methods. To determine the level of HIV-1 DNA, semiquantitative nested polymerase chain reaction was applied using a digoxigenin-labeled primer and chemiluminescence. Serial dilutions of standard HIV DNA were run in parallel with brain DNA samples. Among the 16 AIDS brains studied, 9 showed changes characteristic of HIV encephalitis/leukoencephalopathy while 1 showed focal pontine leukoencephalopathy and 6 showed no obvious neuropathological lesions. Abnormalities in pre-AIDS individuals included meningitis, microgliosis, and astrogliosis. Copy numbers of HIV-1 DNA in the brains of AIDS patients were higher than those in asymptomatic individuals (median, 135 vs 45 copies/150,000 cells). However, there was some degree of overlapping between the two groups, with some AIDS patients showing low figures while 3 asymptomatic individuals had high copy numbers. This suggests that the use of HIV-1 DNA load in the central nervous system as an indicator of progression of the disease should be restricted to large series and not single patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8871581     DOI: 10.1002/ana.410400411

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  9 in total

1.  Canonical type I IFN signaling in simian immunodeficiency virus-infected macrophages is disrupted by astrocyte-secreted CCL2.

Authors:  Luna Alammar Zaritsky; Lucio Gama; Janice E Clements
Journal:  J Immunol       Date:  2012-03-09       Impact factor: 5.422

2.  Genetic diversity and proviral DNA load in different neural compartments of HIV-1 subtype C infection.

Authors:  Mamata Mishra; Rebu K Varghese; Anjali Verma; Sutanuka Das; Renato Santana Aguiar; Amilcar Tanuri; Anita Mahadevan; Susarla K Shankar; Parthasarathy Satishchandra; Udaykumar Ranga
Journal:  J Neurovirol       Date:  2015-03-07       Impact factor: 2.643

3.  Links between progressive HIV-1 infection of humanized mice and viral neuropathogenesis.

Authors:  Santhi Gorantla; Edward Makarov; Jennifer Finke-Dwyer; Antonio Castanedo; Adelina Holguin; Catherine L Gebhart; Howard E Gendelman; Larisa Poluektova
Journal:  Am J Pathol       Date:  2010-11-18       Impact factor: 4.307

4.  GSK3β-activation is a point of convergence for HIV-1 and opiate-mediated interactive neurotoxicity.

Authors:  Ruturaj R Masvekar; Nazira El-Hage; Kurt F Hauser; Pamela E Knapp
Journal:  Mol Cell Neurosci       Date:  2015-01-20       Impact factor: 4.314

5.  Human immunodeficiency virus type 1 infection increases the in vivo capacity of peripheral monocytes to cross the blood-brain barrier into the brain and the in vivo sensitivity of the blood-brain barrier to disruption by lipopolysaccharide.

Authors:  Hongwei Wang; Jinglin Sun; Harris Goldstein
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

Review 6.  Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use illicit drugs.

Authors:  Jeanne E Bell; Juan-Carlos Arango; Iain C Anthony
Journal:  J Neuroimmune Pharmacol       Date:  2006-05-05       Impact factor: 4.147

7.  Detection of infectious agents in brain of patients with acute hemorrhagic leukoencephalitis.

Authors:  Shu F An; Michael Groves; Lillian Martinian; Lu T Kuo; Francesco Scaravilli
Journal:  J Neurovirol       Date:  2002-10       Impact factor: 3.739

8.  Chronic delta-9-tetrahydrocannabinol (THC) treatment counteracts SIV-induced modulation of proinflammatory microRNA cargo in basal ganglia-derived extracellular vesicles.

Authors:  Hussein Kaddour; Marina McDew-White; Miguel M Madeira; Malik A Tranquille; Stella E Tsirka; Mahesh Mohan; Chioma M Okeoma
Journal:  J Neuroinflammation       Date:  2022-09-12       Impact factor: 9.587

9.  The simultaneous presence and expression of human hepatitis C virus (HCV), human herpesvirus-6 (HHV-6), and human immunodeficiency virus-1 (HIV-1) in a single human T-cell.

Authors:  S Zaki Salahuddin; Katherine A Snyder; Andre Godwin; Renu Grewal; John G Prichard; Ann S Kelley; Dennis Revie
Journal:  Virol J       Date:  2007-10-24       Impact factor: 4.099

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.